Elon Musk’s brain-implant company, Neuralink, said that they have received approval from the United States Food and Drug Administration (FDA) for their first in-human clinical trial.
Consumer Sentiment Rises but Misses Expectations
Consumer sentiment rose to 71.8 in November, marking the fourth monthly increase, but fell short of economists’ expectations (73.5) and the earlier 73.0 preliminary reading taken before the election. Wealth advisor Eddy Gifford joins Alicia Read more…